Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System Model 5101 (R20) for the Indication of Overactive Bladder (OAB)

NCT06789406 is registered in ClinicalTrials.gov with Axonics, Inc. as lead sponsor.

NCT NCT06789406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06789406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System Model 5101 (R20) for the Indication of Overactive Bladder (OAB)
Lead sponsor
Axonics, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
September 18, 2025
Completion date
December 31, 2027
Enrollment
55 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder (oab), urinary frequency (uf), urinary urge incontinence (uui)